We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12B
AUM Growth
+$538M
Cap. Flow
+$247M
Cap. Flow %
2.05%
Top 10 Hldgs %
58.6%
Holding
1,163
New
169
Increased
414
Reduced
393
Closed
182

Sector Composition

Rank Sector Weight
1 Energy 67.66%
2 Technology 4.68%
3 Healthcare 3.47%
4 Consumer Discretionary 3.35%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBM icon
951
Hudbay
HBM
$9.92B
$222K ﹤0.01%
45,546
+13,246
+41% +$67.2K
IIPR icon
952
Innovative Industrial Properties
IIPR
$1.78B
$221K ﹤0.01%
2,926
-1,842
-39% -$147K
DOCU
953
DocuSign
DOCU
$9.63B
$221K ﹤0.01%
5,268
-7,009
-57% -$344K
GNL icon
954
Global Net Lease
GNL
$1.87B
$221K ﹤0.01%
22,986
-9,433
-29% -$102K
INDA icon
955
iShares MSCI India ETF
INDA
$6.71B
$214K ﹤0.01%
+4,845
New +$214K
MGNX icon
956
MacroGenics
MGNX
$235M
$213K ﹤0.01%
45,694
+241
+0.5% +$1.2K
NWN icon
957
Northwest Natural Holdings
NWN
$2.17B
$208K ﹤0.01%
+5,444
New +$224K
CMPX icon
958
Compass Therapeutics
CMPX
$373M
$185K ﹤0.01%
94,115
+1,127
+1% +$2.79K
AVIR icon
959
Atea Pharmaceuticals
AVIR
$379M
$185K ﹤0.01%
61,573
+271
+0.4% +$922
VNDA icon
960
Vanda Pharmaceuticals
VNDA
$312M
$183K ﹤0.01%
42,397
+173
+0.4% +$961
OPI
961
DELISTED
Office Properties Income Trust
OPI
$180K ﹤0.01%
43,982
+1,332
+3% +$9.24K
TGB
962
Trekor Metals
TGB
$2.56B
$179K ﹤0.01%
141,250
+41,105
+41% +$56.9K
ENTA icon
963
Enanta Pharmaceuticals
ENTA
$372M
$173K ﹤0.01%
15,497
+21
+0.1% +$338
IE icon
964
Ivanhoe Electric
IE
$1.43B
$169K ﹤0.01%
14,239
+4,140
+41% +$62.1K
ALXO icon
965
ALX Oncology
ALXO
$273M
$146K ﹤0.01%
30,358
+317
+1% +$1.72K
STOK icon
966
Stoke Therapeutics
STOK
$1.82B
$129K ﹤0.01%
32,647
+165
+0.5% +$1.08K
PDSB icon
967
PDS Biotechnology
PDSB
$38.1M
$115K ﹤0.01%
22,822
+164
+0.7% +$898
KPTI icon
968
Karyopharm Therapeutics
KPTI
$168M
$113K ﹤0.01%
5,629
+42
+0.8% +$943
MRSN
969
DELISTED
Mersana Therapeutics
MRSN
$113K ﹤0.01%
3,557
+194
+6% +$9.22K
ALT icon
970
Altimmune
ALT
$539M
$101K ﹤0.01%
38,878
+2,645
+7% +$7.59K
WHWK
971
Whitehawk Therapeutics
WHWK
$183M
$87.6K ﹤0.01%
18,094
+129
+0.7% +$750
WRN
972
Western Copper and Gold
WRN
$485M
$81.4K ﹤0.01%
59,638
+17,844
+43% +$26.5K
NAK
973
Northern Dynasty Minerals
NAK
$885M
$81.3K ﹤0.01%
250,116
+75,004
+43% +$21.2K
NBP
974
NovaBridge Biosciences American Depositary Shares
NBP
$205M
$79.7K ﹤0.01%
60,400
-933
-2% -$2.05K
SLI
975
Standard Lithium
SLI
$517M
$78.3K ﹤0.01%
27,685
+9,789
+55% +$37.6K

Similar funds

ALPS Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, ALPS Advisors held 1,163 positions worth $12B, up 4.7% from $11.5B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

ALPS Advisors's Q3 2023 filing shows 169 new, 414 increased, 393 reduced and 182 closed positions. Its largest new stake was Schwab Fundamental US Large Company Index ETF: 2,126,955 shares worth $39.7M. The largest sale was Magellan Midstream Partners, L.P., an estimated $827M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q3 2023 buy was Schwab Fundamental US Large Company Index ETF: 2,126,955 shares worth $39.7M.
  • ALPS Advisors added most to Enterprise Products Partners in Q3 2023, an estimated $170M increase.
  • ALPS Advisors's biggest Q3 2023 reduction was S&P Global, cutting an estimated $22.8M.
  • ALPS Advisors fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $827M.
  • ALPS Advisors's ten largest holdings make up 59% of its $12B portfolio in Q3 2023.
  • ALPS Advisors opened 169 new positions and closed 182 in Q3 2023.
  • ALPS Advisors's portfolio value rose 4.7% quarter-over-quarter to $12B.

Based on ALPS Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.